Ovoderm®- for Skin, Hair and Nails
Much more than just another collagen product
Ovoderm, delivers an incredibly powerful science-backed branded ingredient, that on top of undenatured collagen type I, V & X, contains hyaluronic acid and elastin. This ingredient provides holistic beauty care in one single ingredient based on eggshell membrane.
- Effective daily intake only 300mg per day (many collagen products require 2.5-5 grams)
- Remarkable capacity to enhance skin moisture
- Veggie collagen
- Backed by science
Remarkable capacity to enhance skin moisture
It has been shown that Ovoderm® has the capacity to restore the skin barrier function by effectively reducing transepidermal water loss. Furthermore, both in vitro and in vivo studies have also proven how Ovoderm® stimulates the fibroblasts (skin cells) to increase the production of both collagen, elastin, and HA. HA is naturally present in eggshell membranes and is considered a key molecule in the skin thanks to its astonishing capacity to retain water. Reduction of skin water loss leaves the skin more plumped reducing the appearance of dry lines. (3)
Clinically proven capacity to fight the main signs of skin ageing
While collagen and elastin fibers in our skin at a young age are plentiful, it rapidly breaks down with natural ageing, leaving our skin less plumped and firm. Ovoderm® contributes to normalization of skin collagen content. The composition of Ovoderm® works by boosting the endogenous collagen production, while inhibiting the activity of the enzymes involved in the degradation of collagen and elastin. This mechanism of action results in enhanced skin elasticity and smoothness and reduction of skin wrinkling. (2,3)
Fights hyperpigmentation and protects against oxidative stress.
The ability of Ovoderm® to influence the melanin production by inhibiting the activity of the tyrosinase enzyme, helps to reduce the appearance of hyperpigmentation and age spots providing a more even skin tone. Furthermore, In vivo studies have shown that Ovoderm® has the capacity to restore the expression levels of the antioxidant enzyme SOD1, which is reduced after UVB-irradiation. SOD1 protects against oxidative damage of the cells by neutralizing free radicals.
Outstanding antioxidant capacity and reduction of oxidative stress driven inflammation
In vivo studies have shown great antioxidant capacity in Ovoderm®, as the product is able to restore the expression levels of the antioxidant enzyme SOD1, which is decreased by UVB-radiation. which can neutralize free radicals. The increased SOD1 production contributes to reduction of oxidative stress driven inflammation induced by UVB-radiation. (1)
There is a wealth of science to support both Ovoderm® and Ovomet®.
- +20 IN VITRO, IN VIVO & CLINICAL STUDIES
- 16 SCIENTIFIC PUBLICATIONS
Eggnovo products come from upcycled and responsibly sourced eggshells avoiding the overconsumption of additional natural resources and the release of Greenhouse Gas (GHG) emissions that are generated when discarded food in landfills decomposes (contributing to tackling climate crisis). Ovoderm® is produced through a chemical free manufacturing process that uses 100 % renewable energy. Additionally, Eggnovo retains the highest value of the whole raw material obtaining also a high added-value calcium ingredient from the eggshell, targeting a zero-waste approach.
- Highly Dispersible
- Improved Density
- Water Soluble
Eggnovo was founded with the commitment to bring together nature, sustainability, science and health to investigate the full potential of these unique eggshell-based ingredients with the aim of improving the well-being of humans and animals.
- Anti‑skin aging activity of eggshell membrane administration and its underlying mechanism
Woo‑Jin Sim1 · Jisong Ahn2 · Wonchul Lim3 · Dong Ju Son4 · Eunjung Lee2 · Tae‑Gyu Lim1,3
- Supplementation with Ovoderm® Reduces the Clinical Signs of Skin Aging. A Double-Blind,Placebo-Controlled Study
Erena Gil-Quintana, Manuel La Nuez and Andres Aguirre*
- Ovoderm® an effective treatment to improve skin condition in
patients with altered skin barrier function
Andrés Aguirre MSc1*, Erena Gil-Quintana PhD1, Manuel La Nuez BSc1